Morningstar analyst report is out for BOQ annual report - the headline "No Major Surprises... and $12 Fair Value Unchanged"
Result was mildly below their expectations and moderately below market consensus.
Comments included weak net interest margin & increase in cost/income ratio and positive remarks on profit growth, lower expense growth guidance and improvement in loan quality.
A notable quote - the soft result was expected and highlighted tough operating conditions facing small regional banks.
Hopefully operating conditions will be on the improve during FY 2017.
SK.
Report
- Forums
- ASX - By Stock
- Morningstar says $12 fair value intact
Morningstar analyst report is out for BOQ annual report - the...
Featured News
Add BOQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.89 |
Change
-0.015(0.22%) |
Mkt cap ! $4.266B |
Open | High | Low | Value | Volume |
$6.91 | $6.94 | $6.85 | $3.601M | 522.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 9064 | $6.88 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.89 | 13466 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 24771 | 9.220 |
3 | 42303 | 9.210 |
8 | 85885 | 9.200 |
7 | 86977 | 9.190 |
11 | 100164 | 9.180 |
Price($) | Vol. | No. |
---|---|---|
9.230 | 15728 | 3 |
9.240 | 64768 | 16 |
9.250 | 116890 | 16 |
9.260 | 105050 | 17 |
9.270 | 79817 | 12 |
Last trade - 11.59am 25/11/2024 (20 minute delay) ? |
Featured News
BOQ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online